Arthur O. Tzianabos
2019
In 2019, Arthur O. Tzianabos earned a total compensation of $5.1M as President and Chief Executive Officer at Homology Medicines, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $295,680 |
|---|---|
| Option Awards | $4,217,097 |
| Salary | $537,600 |
| Other | $12,500 |
| Total | $5,062,877 |
Tzianabos received $4.2M in option awards, accounting for 83% of the total pay in 2019.
Tzianabos also received $295.7K in non-equity incentive plan, $537.6K in salary and $12.5K in other compensation.
Rankings
In 2019, Arthur O. Tzianabos' compensation ranked 2,161st out of 13,971 executives tracked by ExecPay. In other words, Tzianabos earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,161 out of 13,971 | 85th |
Division Manufacturing | 784 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 245 out of 2,200 | 89th |
Industry group Drugs | 198 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 145 out of 1,398 | 90th |
Source: SEC filing on April 28, 2020.
Tzianabos' colleagues
We found two more compensation records of executives who worked with Arthur O. Tzianabos at Homology Medicines in 2019.